CTRI/2019/09/021423Recruiting未知
An Open Label Single Arm Clinical Study To Evaluate The Efficacy AndSafety Of Psoramit Ointment In patients suffering from mild tomoderate Psoriasis
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- The Himalaya Drug Company
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Subject with symptoms of mild to moderate psoriasis with PASI score <10
- •Subject diagnosed with Mild to moderate chronic plaque psoriasis with
- •Palmoplantar psoriasis, Guttate psoriasis, Flexural psoriasis
- •Age >18 to 65 years, both male and female subjects.
- •Physician Global Assessment score of <2
- •Patients willing to sign inform consent document.
Exclusion Criteria
- •Patients with Pustular psoriasis, Erythrodermic psoriasis and psoriatic
- •Subjects treated with other medications / steroids.
- •Significant medical problems such as uncontrolled hypertension /
- •congestive heart failure or any other medication condition
- •Pregnant & Breast feeding Women.
- •History of ongoing, chronic or recurrent infectious disease /
- •lymphoproliferative disease or history of malignancy of any organ
- •system within the past 5 years.
- •History of Alcohol or smoking abuse.
Investigators
Similar Trials
Not yet recruiting
Phase 2
The Single Arm Clinical Study To Evaluate The Effect Of Hingvadi Gutika In Udavarta YonivyapadaCTRI/2024/01/061928SANE GURUJI AROGYA KENDRA
Not yet recruiting
Phase 2
Ayurvedic Management of Anxiety Disorder with Kalyanaka Ghrita Nasya and Saraswatharishtam.CTRI/2024/03/064256Dr. Sumayya Iqra
Not yet recruiting
Phase 2
A Clinical Study to Evalaute the Effect of Bilvaphala majja Avaleha in the Management of Garbhini Chardi(Emesis Gravidarum)CTRI/2023/06/053804Dr Kanchana
Not yet recruiting
Phase 2
The Safety and Efficacy of HQMZ111831 as a Lactation Support to feeding MothersCTRI/2019/09/021400The Himalaya Drug Company
Completed
Phase 4
To evaluate the safety & Efficacy of Baby shampoo in babies of 0 months to 36 monthsCTRI/2023/06/054326Emami Ltd.36